Skip to main content
UniHealth

Doctor search

Neha S Shah, MD

Rheumatology · Stanford

NPI 1144227182

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
17
3 carriers
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Community Hospital of the Monterey Peninsula · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

17 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

17 of 17 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A77436 · Current

Licensed to practise in California · since 2015 · expires 2028-09-30 · University of Florida College of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Illinois 036119828Licensed Physician And Surgeon · since 2007 · expires 2017-07-31
    Not RenewedNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

3 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Community Hospital of the Monterey PeninsulaMonterey, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Montage HealthPatients rate it 4 of 5 · 84% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.48 (1.22 to 1.74), Jul 2022 – Jun 2024Worse than the national rate — Postoperative acute kidney injury requiring dialysis rate: 3.12 (1.69 to 4.56) · 1,095 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 19.24 (14.17 to 24.3) · 1,118 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative sepsis rate: 9.62 (6.42 to 12.82) · 1,086 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025
  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Hospital of the Monterey Peninsula

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Community Hospital of the Monterey Peninsula
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.48 (1.22 to 1.74)WorseJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths3.12 (1.69 to 4.56) · 1,095 casesWorseJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths19.24 (14.17 to 24.3) · 1,118 casesWorseJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths9.62 (6.42 to 12.82) · 1,086 casesWorseJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.39BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.27 (0.39 to 2.16) · 1,873 casesNo differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths158.2 (110.65 to 205.75) · 140 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.3 · 74 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.8 · 135 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 184 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.7 · 686 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths16.4 · 1,072 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8 · 328 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.8 · 3,300 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.29 (0.11 to 0.48) · 10,234 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.1 to 0.46) · 10,572 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.25 (1.47 to 5.04) · 2,617 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.37 (1.04 to 3.7) · 2,519 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths2.21 (0.75 to 3.66) · 744 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.61 (0.06 to 1.17) · 8,715 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths5.2 · 156 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.28No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.799No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.732No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.7 · 152 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.6 · 625 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits6.3 · 193 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-3.2 · 749 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits7 · 1,074 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.5 · 850 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4 (2.7 to 5.8) · 224 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits13.5 (10.4 to 17.4) · 224 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 153 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11.5 · 49 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.2 (10.9 to 18.6) · 711 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (1 to 1.5) · 746 casesNo differentJan 2024 – Dec 2024

What patients said (520 patients answered, 28% of those asked)

Patient survey stars by topic at Community Hospital of the Monterey Peninsula
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating5
Quietness3
Recommend hospital5
Share of patients giving the best answer at Community Hospital of the Monterey Peninsula
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained62%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge84%
Doctors "always" explained things so they could understand75%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect89%
Patients who gave a rating of "9" or "10" (high)82%
Staff "always" explained new medications79%
Nurses "always" explained things so they could understand79%
Nurses "always" listened carefully77%
Nurses "always" treated them with courtesy and respect89%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital84%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms88%
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$43,544

Medicare paid this office $43,544 for 165 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)104$18,824$114
Long return visit (40+ min)33$8,025$164
Short return visit (20+ min)48$5,085$83
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's122$3,289$15
New patient visit (60+ min)17$3,237$190
See all 6 services
Every Original Medicare service billed
Return visit (30+ min)104$18,824$114
Long return visit (40+ min)33$8,025$164
Short return visit (20+ min)48$5,085$83
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's122$3,289$15
New patient visit (60+ min)17$3,237$190
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's11$165$15

Who their Medicare patients are

165 Original Medicare patients in 2024. Average age 71 · Women 71% · Also on Medicaid 23% · Health risk score 1.64. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 67% · Coronary heart disease 33% · Chronic kidney disease 29% · Diabetes 28% · Depression 21% · Cancer 18% · Atrial fibrillation 18% · Heart failure 17% · COPD 13% · Stroke 8%.

The office billed $246,648, Medicare allowed $57,942 and paid $43,544; for 604 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024165604711.64$246,648$43,544
2023172384702.03$238,468$34,659
2022119293701.72$159,592$22,775
2021146328691.69$181,172$30,180
2020117309682.01$165,404$24,464
2019101216692.02$117,952$20,750
201890173691.54$64,628$16,598
201791186691.92$74,388$18,710
201676164691.45$50,645$14,927
20154076701.84$26,939$8,114
2014169316721.27$42,180$18,577
2013224687721.23$85,133$37,556

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Return visit (30+ min)76$9,255$81
Initial hospital care with moderate level of medical decision making at least 75 minutes31$4,958$160
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$4,717$110
Return visit (30+ min)33$4,692$109
Short return visit (20+ min)33$1,841$50
Long return visit (40+ min)12$1,729$133
Telehealth originating site facility fee14$348$20

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)53$7,389$83
Return visit (30+ min)26$4,289$116
Short return visit (20+ min)34$2,629$51
Short return visit (20+ min)17$1,306$73
Telehealth originating site facility fee25$588$20

2021: 6 services

Original Medicare services billed in 2021
Return visit (30+ min)68$9,045$91
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes17$3,627$95
Short return visit (20+ min)44$3,296$60
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,591$185
Return visit (30+ min)17$2,121$118
Telehealth originating site facility fee14$303$22

2020: 7 services

Original Medicare services billed in 2020
Return visit (30+ min)60$8,191$94
Initial hospital care with moderate level of medical decision making at least 75 minutes15$2,865$191
Return visit (30+ min)33$2,570$71
Long return visit (40+ min)12$1,606$124
Telehealth originating site facility fee53$1,361$21
Short return visit (20+ min)24$1,162$46
Short return visit (20+ min)11$782$71

2019: 4 services

Original Medicare services billed in 2019
Return visit (30+ min)61$8,146$87
New patient visit (60+ min)24$3,886$162
Long return visit (40+ min)20$3,704$119
Return visit (30+ min)15$1,032$65

2018: 3 services

Original Medicare services billed in 2018
Long return visit (40+ min)57$8,623$98
New patient visit (60+ min)28$4,038$144
Return visit (30+ min)23$2,213$76

2017: 3 services

Original Medicare services billed in 2017
Long return visit (40+ min)38$7,518$103
New patient visit (60+ min)30$4,731$158
Return visit (30+ min)19$1,741$73

2016: 4 services

Original Medicare services billed in 2016
Long return visit (40+ min)35$4,731$89
New patient visit (60+ min)29$4,329$149
Return visit (30+ min)18$2,174$66
New patient visit (45+ min)11$1,154$105

2015: 1 service

Original Medicare services billed in 2015
New patient visit (60+ min)16$2,404$150

2014: 5 services

Original Medicare services billed in 2014
Return visit (30+ min)105$8,416$58
Long return visit (40+ min)28$3,412$87
Aspiration and/or injection of fluid from large joint34$2,088$44
Short return visit (20+ min)43$1,637$33
New patient visit (45+ min)11$1,119$102

2013: 6 services

Original Medicare services billed in 2013
Return visit (30+ min)161$18,109$59
Aspiration and/or injection of fluid from large joint45$4,472$35
New patient visit (45+ min)39$3,957$101
Short return visit (20+ min)71$3,615$38
Long return visit (40+ min)17$2,131$82
Short return visit15$355$19

Medicaid work

$2,835 in 2023

Medicaid paid $2,835 for 68 billed services this clinician did in 2023, up to 15 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
Return visit (30+ min)42$1,732
SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES26$1,103
Medicaid work by year
202368215$2,835

Drugs they prescribed that Part D paid

$959,700

Pharmacies billed $959,700 in 2024. Most of that is one immune-globulin drugs at about $19,000 a fill for a small number of people.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 581) in 2024. At or below the middle of the specialty; the typical rheumatology clinician is at 3%.

463 generic and fewer than 11 brand-name prescriptions · $959,700 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
PrivigenImmune globulin13$251,568$19,351
HumiraNone11$83,694$7,609
RinvoqNone13$83,153$6,396
Mycophenolate MofetilNone27$4,986$185
Hydroxychloroquine SulfateNone42$2,853$68
See all 13 drugs
Every Part D drug this clinician prescribed
PrivigenImmune globulin13$251,568$19,351
HumiraNone11$83,694$7,609
RinvoqNone13$83,153$6,396
Mycophenolate MofetilNone27$4,986$185
Hydroxychloroquine SulfateNone42$2,853$68
MethotrexateNone102$2,786$27
LeflunomideNone23$1,523$66
PrednisoneNone93$1,349$15
DuloxetineNone21$426$20
MethotrexateNone22$338$15
Folic AcidNone14$206$15
AllopurinolNone26$163$6
MethylprednisoloneNone17$99$6

Year by year

Part D prescribing by year
20245811080% (0)None$959,700
202357997NoneNone$683,487
202258275NoneNone$617,010
202158886NoneNone$548,370
202065385None19%$421,727
201961273NoneNone$362,347
201864166NoneNone$306,360
201758866NoneNone$170,685
201645357NoneNone$77,141
201516847None20%$18,585
20147931417% (55)28%$140,465
20131,08014711% (114)None$148,950

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 16 drugs

Part D drugs prescribed in 2023
Xeljanz27$177,469$6,573
Humira19$142,880$7,520
Cimzia12$78,057$6,505
Azathioprine13$5,664$436
Mycophenolate Mofetil24$3,382$141
Febuxostat15$3,117$208
Leflunomide43$3,100$72
Methotrexate85$2,826$33
Hydroxychloroquine Sulfate50$2,321$46
Colchicine16$1,505$94
Prednisone94$1,072$11
Methotrexate16$317$20
Allopurinol27$290$11
Amitriptyline12$245$20
Duloxetine13$191$15
Methylprednisolone12$141$12

2022: 15 drugs

Part D drugs prescribed in 2022
Xeljanz30$193,262$6,442
Cimzia15$131,226$8,748
Humira15$102,566$6,838
Hydroxychloroquine Sulfate64$4,119$64
Methotrexate88$4,118$47
Mycophenolate Mofetil24$3,625$151
Colchicine19$2,518$133
Febuxostat12$2,082$174
Leflunomide23$1,943$84
Prednisone90$1,361$15
Allopurinol30$467$16
Methotrexate22$425$19
Amitriptyline24$311$13
Duloxetine19$253$13
Methylprednisolone16$106$7

2021: 16 drugs

Part D drugs prescribed in 2021
Xeljanz31$179,173$5,780
Cimzia16$114,810$7,176
Hydroxychloroquine Sulfate62$6,259$101
Methotrexate98$4,667$48
Leflunomide32$3,877$121
Colchicine13$2,730$210
Mycophenolate Mofetil20$2,267$113
Prednisone89$1,047$12
Febuxostat14$903$64
Duloxetine32$710$22
Sulfasalazine Dr13$582$45
Methylprednisolone19$373$20
Methotrexate16$274$17
Amitriptyline17$217$13
Allopurinol14$168$12
Cyclobenzaprine12$31$3

2020: 13 drugs

Part D drugs prescribed in 2020
Xeljanz27$136,780$5,066
Mycophenolate Mofetil18$7,855$436
Hydroxychloroquine Sulfate99$7,398$75
Leflunomide36$5,099$142
Methotrexate135$4,666$35
Diclofenac30$3,193$106
Colchicine11$1,946$177
Prednisone78$1,082$14
Sulfasalazine Dr18$869$48
Duloxetine30$571$19
Methylprednisolone18$247$14
Methotrexate14$230$16
Allopurinol13$104$8

2019: 14 drugs

Part D drugs prescribed in 2019
Xeljanz20$89,578$4,479
Humira12$61,440$5,120
Mycophenolate Mofetil27$7,707$285
Leflunomide38$5,930$156
Hydroxychloroquine Sulfate61$5,687$93
Methotrexate119$4,418$37
Cevimeline11$2,734$249
Diclofenac30$2,512$84
Colchicine13$1,979$152
Prednisone88$986$11
Duloxetine21$627$30
Methotrexate19$238$13
Meloxicam15$30$2
Alendronate14$25$2

2018: 12 drugs

Part D drugs prescribed in 2018
Xeljanz15$63,016$4,201
Leflunomide51$8,196$161
Hydroxychloroquine Sulfate70$7,160$102
Colchicine27$6,145$228
Mycophenolate Mofetil26$5,575$214
Methotrexate103$4,948$48
Voltaren13$3,264$251
Duloxetine34$891$26
Prednisone91$813$9
Methylprednisolone14$167$12
Meloxicam23$57$2
Alendronate12$20$2

2017: 16 drugs

Part D drugs prescribed in 2017
Hydroxychloroquine Sulfate49$6,281$128
Leflunomide41$6,112$149
Methotrexate96$4,978$52
Colcrys16$4,703$294
Colchicine18$3,569$198
Diclofenac12$1,213$101
Duloxetine40$934$23
Prednisone88$889$10
Sulfasalazine Dr16$776$48
Sulfasalazine18$387$21
Methylprednisolone12$222$18
Allopurinol12$172$14
Methotrexate12$148$12
Meloxicam25$72$3
Cyclobenzaprine14$25$2
Alendronate12$19$2

2016: 11 drugs

Part D drugs prescribed in 2016
Hydroxychloroquine Sulfate71$9,705$137
Leflunomide15$3,069$205
Methotrexate76$2,761$36
Duloxetine42$1,990$47
Diclofenac12$1,802$150
Prednisone65$1,104$17
Mycophenolate Mofetil11$904$82
Sulfasalazine14$400$29
Allopurinol14$222$16
Sulfasalazine Dr11$187$17
Sulfamethoxazole-Trimethoprim14$46$3

2015: 4 drugs

Part D drugs prescribed in 2015
Methotrexate37$2,518$68
Hydroxychloroquine Sulfate13$1,653$127
Duloxetine17$991$58
Prednisone22$418$19

2014: 15 drugs

Part D drugs prescribed in 2014
Methotrexate111$10,827$98
Duloxetine47$7,942$169
Colcrys20$5,245$262
Mycophenolate Mofetil23$4,061$177
Voltaren30$3,832$128
Hydroxychloroquine Sulfate84$3,417$41
Celebrex12$3,340$278
Azulfidine14$1,990$142
Leflunomide34$1,468$43
Prednisone86$1,154$13
Hydrocodone-Acetaminophen38$881$23
Methylprednisolone20$545$27
Methotrexate18$290$16
Latanoprost17$256$15
Meloxicam19$138$7

2013: 18 drugs

Part D drugs prescribed in 2013
Cymbalta60$17,721$295
Methotrexate127$9,752$77
Colcrys37$6,093$165
Lyrica18$4,384$244
Hydroxychloroquine Sulfate114$3,900$34
Celebrex16$3,333$208
Mycophenolate Mofetil23$2,793$121
Leflunomide52$2,035$39
Hydrocodone-Acetaminophen70$1,825$26
Prednisone93$940$10
Methylprednisolone26$756$29
Sulfasalazine13$517$40
Atorvastatin12$462$39
Dapsone11$441$40
Meloxicam36$379$11
Tramadol16$244$15
Methocarbamol11$150$14
Allopurinol20$125$6

Money from drug and device companies

$50 in 2023

Industry payments by year
202311None$50
202211None$82
201911None$20

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbVieRinvoq$50
1 payment
  • Meals for Rinvoq · 2023-04-01 · $50
See the published payment
Every published payment
AbbVieMeals · 2023-04-01Rinvoq$50
See earlier years (2022, 2019)

2022: $82

Payments by company in 2022
Aurinia Pharma U.S.Lupkynis$82
1 payment
  • Meals for Lupkynis · 2022-11-12 · $82

2019: $20

Payments by company in 2019
Otsuka America PharmaceuticalRexulti$20
1 payment
  • Meals for Rexulti · 2019-06-13 · $20

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1144227182
Licence
CA A77436, IL 036.119828California A77436: Current · expires 2028-09-30Illinois 036119828: Not Renewed
Trained
University of Florida College of Medicine, 1999
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RR0500X (207RR0500X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2005-07-06
NPI last updated
2024-04-16
NPI record certified
2024-04-16

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 1000 Welch Rd, Palo Alto, CA, 94304 · 900 Blake Wilbur Dr, Palo Alto, CA, 94304